News & Views
Collaboration to advance Global Drug Discovery Infrastructure
Nov 26 2020
Drug discovery software developer Optibrium has announced a collaboration with US-based MSD which has adopted the Cambridge, UK company's StarDrop™ software as a central component of their cheminformatics infrastructure. The partnership will also include the joint development of new tools, to improve cycle times, efficiency and productivity of the drug discovery process.
Dr Matthew Segall, Optibrium’s CEO, commented, “We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”
MSD is a tradename of Merck & Co Inc, Kenilworth NJ
Further information www.online
In This Edition Chromatography Articles - Faster and automated analysis of aroma compounds in cosmetics Mass Spectrometry & Spectroscopy Articles - Frequently Asked Questions (FAQ) abou...
View all digital editions
Oct 05 2023 Gandhinagar, India
Oct 10 2023 Hybrid event
Oct 18 2023 Liverpool, UK
Oct 23 2023 Beijing, China
Oct 24 2023 Glasgow, Scotland, UK